Robocentric AI and robotics directive
Continuously develop and commercialize humanlike artificial intelligence and robotics technology products for doubling the American annual national GDP to US$50 trillion, US$25 trillion more than the pre-robotization level, by adding 300 million or more AI and robot workers that are managed by human workers to the American national economy.
Robocentric biotech directives
Continuously develop and commercialize the Robocentric core biotechnologies of the Robocentric scanner, modeler, designer, synthesizer, and replacer biotechnologies toward realizing the Robocentric human body part and whole human body manufacturing and replacement biotech, human body resurrection biotech, anti-aging human body biotech, human body rejuvenation biotech, human body longevity biotech, medical and cosmetic and behavioral human genetic engineering biotech, neurotech, and interplanetary human body teleporter biotech.
Continuously develop and commercialize the Robocentric core biotechnology derived products that are used in advancing science, technology, and capitalism.
Proactively and preemptively develop and make available the cure and defense for every existing and possible viral and bacterial disease and bioweapon attack, using the Robocentric scanner, modeler, designer, synthesizer, and replacer biotechnologies.
Continuously develop and commercialize human-food production biotechnologies.
Continuously develop and commercialize consumer and industrial synthetic biomatter.
Robocentric outer-space tech directives
Continuously develop and commercialize the Robocentric mass-scale outer space transportation, mining, manufacturing, construction, communication, and human-habitat management and maintenance technologies that enable the interplanetary, interstellar, and intergalactic mass-scale outer space humanity expansion.
For more information on how Robocentric advances AI, robotics, human body biotech, and mass-scale outer space tech, read The Future, available at Robocentric.com/Future.